Cardiac Arrhythmia Clinical Trials
2 recruiting trials for Cardiac Arrhythmia. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Cardiac Arrhythmia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Pulse Biosciences, Inc. (1), Mayo Clinic (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is CellFX nsPFA Cardiac Catheter System (device, 1 trial).
Track Cardiac Arrhythmia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
The objective of this study is to demonstrate the safety and effectiveness of the CellFX nano-second Pulsed Field Ablation (nsPFA) Cardiac Catheter Ablation System in treating...
Mayo AVC Registry and Biobank
Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Cardiac Arrhythmia, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Cardiac Arrhythmia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Cardiac Arrhythmia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.